Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score–Matching Analysis
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging
Reference31 articles.
1. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study;Park;Liver Int,2015
2. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials;Llovet;Hepatology,1999
3. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition);Zhou;Liver Cancer,2018
4. EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018
5. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE;Journal of Gastroenterology and Hepatology;2024-01-19
2. Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. Review of the Literature;Journal of oncology: diagnostic radiology and radiotherapy;2023-12-16
3. The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization;Journal of Hepatocellular Carcinoma;2023-12
4. Anlotinib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma associated with hepatitis B virus: a retrospective controlled study;Frontiers in Oncology;2023-11-22
5. Transarterial chemoembolization versus hepatic arterial infusion chemotherapy as initial treatment for stage CNLC Ⅲa hepatocellular carcinoma;2023-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3